| P50 | author | Gareth J. Barker | Q42305700 |
| | Brian Hallahan | Q42856863 |
| P2093 | author name string | Cathy Scanlon | |
| | Colm McDonald | |
| | Dara M Cannon | |
| | Heike Schmidt | |
| | Peter McCarthy | |
| | Mohamed Ahmed | |
| | Camilla Langan | |
| | John McFarland | |
| | Laurena Holleran | |
| P2860 | cites work | The myth of schizophrenia as a progressive brain disease | Q24067152 |
| | Cortical Surface-Based Analysis | Q28124697 |
| | The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 |
| | The neuropathology of schizophrenia. A critical review of the data and their interpretation | Q30573678 |
| | The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. | Q31657420 |
| | Effects of antipsychotics on brain structure | Q33239807 |
| | Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings | Q33425487 |
| | Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 |
| | The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis | Q33865677 |
| | The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys | Q33985626 |
| | Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review | Q34034400 |
| | Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies | Q34120168 |
| | Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. | Q34174069 |
| | Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. | Q34351095 |
| | Antipsychotic drug effects on brain morphology in first-episode psychosis | Q34408860 |
| | Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys | Q34576434 |
| | Within-subject template estimation for unbiased longitudinal image analysis | Q36075413 |
| | Gray matter volume decreases in elderly patients with schizophrenia: a voxel-based morphometry study | Q36121482 |
| | Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects | Q37131066 |
| | Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia | Q37480943 |
| | Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia | Q43582604 |
| | Cortical signature of neurological soft signs in recent onset schizophrenia | Q43989192 |
| | Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus | Q44793041 |
| | Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison | Q44814427 |
| | Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus | Q44882892 |
| | A comparison of MR based segmentation methods for measuring brain atrophy progression | Q45794351 |
| | Changes in cortical thickness during the course of illness in schizophrenia. | Q45927962 |
| | Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine | Q46310735 |
| | Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia | Q46693287 |
| | The effects of clozapine on delayed spatial alternation deficits in rats with hippocampal damage | Q46743111 |
| | Progressive brain volume loss during adolescence in childhood-onset schizophrenia | Q47364106 |
| | Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood | Q48122360 |
| | Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study | Q48258798 |
| | Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. | Q48286419 |
| | Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. | Q48407980 |
| | Brain volume changes in first-episode schizophrenia: a 1-year follow-up study | Q48452819 |
| | Ventricular enlargement in poor-outcome schizophrenia | Q48457497 |
| | A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures | Q48519543 |
| | Normalized accurate measurement of longitudinal brain change | Q48881982 |
| | Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. | Q51878068 |
| | Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. | Q51898368 |
| | The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance | Q52112284 |
| | Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. | Q55053712 |
| | Changes in caudate volume with neuroleptic treatment | Q72824681 |
| | Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients | Q80321645 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 2409-2417 | |
| P577 | publication date | 2015-04-01 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment | |
| P478 | volume | 40 | |